Exicure (XCUR) Change in Acquisitions & Divestments (2020 - 2024)
Exicure's (XCUR) quarterly Change in Acquisitions & Divestments came in at $2.1 million in Q1 2024, up 104400.0% on a QoQ basis from $2000.0 in Q4 2022.
Exicure (XCUR) Change in Acquisitions & Divestments (2020 - 2024) Analysis & Trends
Exicure (XCUR) has 4 years of Change in Acquisitions & Divestments data on file, last reported at $2.1 million in Q1 2024.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $2.1 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $2.1 million (down 16.4% YoY) and the FY2022 annual result came in at $6.0 million, down 88.13% from the prior year.
- Change in Acquisitions & Divestments climbed to $2.1 million in Q1 2024, from $2000.0 in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $22.9 million in Q4 2020 to a low of $2000.0 in Q4 2022.
- A 4-year average of $9.9 million and a median of $9.0 million in 2021 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2021 — Change in Acquisitions & Divestments surged 55.22% — and 2022, when it sank 99.96%.
- Tracing XCUR's Change in Acquisitions & Divestments over 4 years: stood at $22.9 million in 2020, then plunged by 80.52% to $4.5 million in 2021, then slumped by 99.96% to $2000.0 in 2022, then soared by 104400.0% to $2.1 million in 2024.
- The last three Change in Acquisitions & Divestments figures came in at $2.1 million (Q1 2024), $2000.0 (Q4 2022), and $998000.0 (Q3 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 2.09 Mn |
| Mar 31, 2024 | 2.09 Mn |
| Dec 31, 2022 | 2,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 998,000.00 |
| Sep 30, 2022 | 998,000.00 |
| Jun 30, 2022 | 1.50 Mn |
| Jun 30, 2022 | 1.50 Mn |
| Mar 31, 2022 | 3.50 Mn |
| Mar 31, 2022 | 3.50 Mn |
| Dec 31, 2021 | 4.45 Mn |
| Dec 31, 2021 | 4.45 Mn |
| Sep 30, 2021 | 9.00 Mn |
| Sep 30, 2021 | 9.00 Mn |
| Jun 30, 2021 | 21.58 Mn |
| Jun 30, 2021 | 21.58 Mn |
| Mar 31, 2021 | 15.52 Mn |
| Mar 31, 2021 | 15.52 Mn |
| Dec 31, 2020 | 22.86 Mn |
| Dec 31, 2020 | 22.86 Mn |